Alterations of INK4a(p16-p14ARF)/INK4b(p15) expression and telomerase activation in meningioma progression (Q28203138)

1

0 references

T W Park

2

0 references

G Köster

3

0 references

R Mahlberg

4

0 references

M Hackenbroch

5

0 references

J Boström

6

0 references

T Löning

7

0 references

J Schramm

Journal of Neuro-Oncology

8

0 references

language of work or name

English

0 references

publication date

December 2001

0 references

published in

0 references

volume

55

0 references

issue

3

0 references

page(s)

149-58

0 references

cites work

Expression of p53, MDM2 protein and Ki-67 antigen in recurrent meningiomas

1 reference

12 December 2020

Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a

1 reference

12 December 2020

Exogenous expression of p16INK4a is associated with decrease in telomerase activity

1 reference

12 December 2020

Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest

1 reference

12 December 2020

Long-term prognosis for atypical and malignant meningiomas: a study of 71 surgical cases

1 reference

12 December 2020

Telomerase activation. One step on the road to cancer?

1 reference

12 December 2020

Cloning and characterization of p10, an alternatively spliced form of p15 cyclin-dependent kinase inhibitor

1 reference

12 December 2020

Analysis of cell cycle regulators: p16INK4A, pRb, and CDK4 in low- and high-grade meningiomas

1 reference

12 December 2020

Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells.

1 reference

12 December 2020

Detection of TP53 gene mutation in human meningiomas: a study using immunohistochemistry, polymerase chain reaction/single-strand conformation polymorphism and DNA sequencing techniques on paraffin-embedded samples

1 reference

12 December 2020

Can ends justify the means?: telomeres and the mechanisms of replicative senescence and immortalization in mammalian cells

1 reference

12 December 2020

Homozygous deletions of the CDKN2/p16 gene in dural hemangiopericytomas

1 reference

12 December 2020

Germ-line deletion involving the INK4 locus in familial proneness to melanoma and nervous system tumors.

1 reference

12 December 2020

Meningioma grading: an analysis of histologic parameters

1 reference

12 December 2020

Frequency of homozygous deletion at p16/CDKN2 in primary human tumours

1 reference

12 December 2020

Establishment and characterization of a human leptomeningeal cell line.

1 reference

12 December 2020

Replicative senescence: implications for in vivo aging and tumor suppression

1 reference

12 December 2020

Adenovirus-mediated overexpression of p15INK4B inhibits human glioma cell growth, induces replicative senescence, and inhibits telomerase activity similarly to p16INK4A.

1 reference

12 December 2020

Functional evidence for a role of combined CDKN2A (p16-p14(ARF))/CDKN2B (p15) gene inactivation in malignant gliomas.

1 reference

12 December 2020

Telomerase activity and expression of the telomerase catalytic subunit, hTERT, in meningioma progression

1 reference

12 December 2020

Infrequent alterations of the p15, p16, CDK4 and cyclin D1 genes in non-astrocytic human brain tumors.

1 reference

12 December 2020

Splicing into senescence: the curious case of p16 and p19ARF.

1 reference

12 December 2020

A survey of telomerase activity in human cancer

1 reference

12 December 2020

Atypical and anaplastic meningiomas: radiology, surgery, radiotherapy, and outcome

1 reference

12 December 2020

Involvement of the Ink4 proteins p16 and p15 in T-lymphocyte senescence

1 reference

12 December 2020

Frequent and selective methylation of p15 and deletion of both p15 and p16 in T-cell acute lymphoblastic leukemia

1 reference

12 December 2020

Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression

1 reference

12 December 2020

p16(INK4a) and the control of cellular proliferative life span.

1 reference

12 December 2020

The telomerase reverse transcriptase: components and regulation

1 reference

12 December 2020

5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers

1 reference

12 December 2020

Allelic losses on chromosomes 14, 10, and 1 in atypical and malignant meningiomas: a genetic model of meningioma progression

1 reference

12 December 2020

1 reference

12 December 2020

Refining the telomere-telomerase hypothesis of aging and cancer

1 reference

12 December 2020

The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53

1 reference

12 December 2020

The human p19ARF protein encoded by the beta transcript of the p16INK4a gene is frequently lost in small cell lung cancer

1 reference

12 December 2020

Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF

1 reference

12 December 2020

ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways

1 reference

12 December 2020

Alternative splicing of the p15 cdk inhibitor in glioblastoma multiforme.

1 reference

12 December 2020

Deletion of p16 and p15 genes in brain tumors

1 reference

12 December 2020

A cell cycle regulator potentially involved in genesis of many tumor types

1 reference

12 December 2020

Differential telomerase activity, expression of the telomerase catalytic sub-unit and telomerase-RNA in ovarian tumors

1 reference

12 December 2020